FREE SHIPPING ON ORDERS OVER $150

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

$28.23

Quantity
- +
Description

Caffeine interacts with the liver enzyme CYP1A2

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

doi: 10.1016/j.neulet.2017.07.059

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

Most studies have focused on specific medical conditions over relatively short periods

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

Biomarkers and their impact on precision medicine

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

Kumar A, Kaundal RK, Iyer S, Sharma SS

l carnitine in renal failure dysregulation diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine NKF KDOQI Guidelines

You may also like

recommand products